Advertisement
Singapore markets closed

  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • Dow

    37,753.31
    -45.66 (-0.12%)
     

  • Nasdaq

    15,683.37
    -181.88 (-1.15%)
     

  • Bitcoin USD

    62,690.39
    -364.41 (-0.58%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • FTSE 100

    7,861.32
    +13.33 (+0.17%)
     

  • Gold

    2,397.40
    +9.00 (+0.38%)
     

  • Crude Oil

    82.25
    -0.44 (-0.53%)
     

  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     

  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     

  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     

  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     

  • Jakarta Composite Index

    7,166.81
    +35.97 (+0.50%)
     

  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Teladoc (TDOC) Q4 Loss Wider Than Expected, Revenues Beat

Zacks Equity Research
Updated

Teladoc Inc.’s TDOC fourth-quarter 2017 operating loss of 50 cents per share was wider than the Zacks Consensus Estimate of a loss of 40 cents. In the year-ago quarter, the company had incurred a loss of 31 cents per share.

Strong Operational Performance    

Total revenues of $77 million not only surpassed the Zacks Consensus Estimate of $76 million but also surged 106% year over year. This is above the company’s preliminary reported revenues of $76 million. The increase in top line was driven mainly by a 115% rise in revenues from subscription access fees to $65.4 million, which benefited from the acquisition of Best Doctors.

Revenues from visits increased 68% year over year to $11.8 million. Total visits of 464,000 surged 54% year over year. Total U.S. paid membership was 23.2 million, reflecting an increase of 33% year over year.

ADVERTISEMENT

Teladoc, Inc. Price, Consensus and EPS Surprise

Teladoc, Inc. Price, Consensus and EPS Surprise | Teladoc, Inc. Quote

Total operating expenses were $78.98 million, 94.5% higher year over year. The rise was due to increased expenditure on advertising & marketing, sales, technology & development, acquisition related costs, general & administrative expenses as well as depreciation & amortization costs.

Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $2.4 million compared with the loss of $10.6 million in the year-ago quarter. The company, which was till the third quarter of 2017 posting negative EBIDTA (due to huge development marketing and investments quite common for a company in its inception phase, which outpaced revenue growth), delivered on its promise of a breakeven EBIDTA in the fourth quarter.

Financial Position

Teladoc’s total assets were approximately $824.4 million as of Dec 31, 2017, up from $303.7 million as of Dec 31, 2016.

Total cash, cash equivalents were $42.8 million as of Dec 31, 2017, down 14.4% year over year.

First Quarter 2018 Guidance

Net loss per share, based on 61.9 million weighted average shares outstanding, is expected between 43 cents and 45 cents. Revenues are expected in the range of $86-$88 million; adjusted EBITDA in the range of loss of $2.5-$3.5 million.  

Total U.S. paid membership is expected between 19.5 million and 20 million, and visit fee only access should be within 9.0-9.25 million individuals.

Total visits are projected between 575,000 and 625,000.

2018 Guidance

The company expects net loss per share, based on 62.8 million weighted average shares outstanding, between $1.36 and $1.41; revenues of $350 million to $360 million; adjusted EBITDA between $7 million and $10 million and total U.S. paid membership within 22 million to 24 million.

Total visits are projected between 1.9 million and 2 million.

Our Take

The company’s results reflect its rapidly expanding business in the booming telehealth services industry. Higher adoption of its services has led to an increase in membership and visits, which has flown through revenue growth.  

Zacks Rank & Performance of Other Insurers

Teladoc currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Among the other firms in the medical sector that have reported fourth-quarter earnings so far, the bottom lines of Anthem Inc. ANTM, Aetna Inc. AET and UnitedHealth Group Inc. UNH beat their respective Zacks Consensus Estimate.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Aetna Inc. (AET) : Free Stock Analysis Report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Anthem, Inc. (ANTM) : Free Stock Analysis Report
 
Teladoc, Inc. (TDOC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research